Portea Medical acquires MedybizPharma for undisclosed amount
Advertisement
New Delhi: Portea Medical, a home healthcare company, has acquired speciality pharmaceutical distributor MedybizPharma for an undisclosed amount.
The cash and stock deal will enable Portea to strengthen patient engagement and provide better care for chronic disease patients in India, the company said in a statement.
"A structured and integrated approach enveloping awareness, monitoring and ongoing disease management is vital to tackle the battle India faces with chronic diseases.
"While hospital-based treatments are important, continuing care delivered to patients at home is a key prong of effective treatment," Portea Medical MD and CEO Meena Ganesh said.
With the acquisition of Medybiz, Portea is adding a vital, powerful and specialised pharma arm to deliver better pharmacy care to patients with chronic conditions who have ongoing needs for medication, she added.
MedybizPharma, which started in 2009, serves more than two lakh patients, providing prescription refill and therapy compliance support for super-speciality medicines.
Headquartered in Bengaluru, Medybiz has 200 employees and a footprint across 26 cities. The company was acquired from the Reliance ADA group by its management team in 2011.
Portea Medical handles over 60,000 home visits a month across 24 cities in India. In September this year, it received Series B funding of USD 37.5 million from Accel, IFC, Qualcomm Ventures and Ventureast.
The cash and stock deal will enable Portea to strengthen patient engagement and provide better care for chronic disease patients in India, the company said in a statement.
"A structured and integrated approach enveloping awareness, monitoring and ongoing disease management is vital to tackle the battle India faces with chronic diseases.
"While hospital-based treatments are important, continuing care delivered to patients at home is a key prong of effective treatment," Portea Medical MD and CEO Meena Ganesh said.
With the acquisition of Medybiz, Portea is adding a vital, powerful and specialised pharma arm to deliver better pharmacy care to patients with chronic conditions who have ongoing needs for medication, she added.
MedybizPharma, which started in 2009, serves more than two lakh patients, providing prescription refill and therapy compliance support for super-speciality medicines.
Headquartered in Bengaluru, Medybiz has 200 employees and a footprint across 26 cities. The company was acquired from the Reliance ADA group by its management team in 2011.
Portea Medical handles over 60,000 home visits a month across 24 cities in India. In September this year, it received Series B funding of USD 37.5 million from Accel, IFC, Qualcomm Ventures and Ventureast.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.